Onderneming Parnell Pharmaceuticals Holdings Ltd Other OTC
Aandelen
PARNF
AU0000XINEU9
Farmaceutische producten
Vakgebied
Verkoop per activiteit
USD in miljoen | 2017 | Gewicht | 2018 | Gewicht | Delta |
---|---|---|---|---|---|
Production Animal - U.S.
41,2
%
| 7 | 48,0 % | 8 | 41,2 % | +16,22% |
Manufacturing
38,9
%
| 3 | 22,7 % | 8 | 38,9 % | +131,78% |
Companion Animal
11,9
%
| 3 | 17,1 % | 2 | 11,9 % | -5,90% |
Production Animal - Rest of World
7,9
%
| 2 | 12,2 % | 2 | 7,9 % | -12,18% |
Verkoop per regio
USD in miljoen | 2017 | Gewicht | 2018 | Gewicht | Delta |
---|---|---|---|---|---|
United States
84,0
%
| 11 | 77,7 % | 17 | 84,0 % | +46,20% |
Australia
11,8
%
| 2 | 14,1 % | 2 | 11,8 % | +13,76% |
Other Countries
2,6
%
| 1 | 6,7 % | 1 | 2,6 % | -46,85% |
New Zealand
1,5
%
| 0 | 1,6 % | 0 | 1,5 % | +32,65% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01-02-10 |
Joe Rosentel
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Pablo Lamberto
COO | Chief Operating Officer | - | - |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jay Benear
BRD | Director/Board Member | - | - |
Doug Schillinger
BRD | Director/Board Member | 50 | - |
Eric Moore
BRD | Director/Board Member | - | 21-12-20 |
Brad R. McCarthy
CEO | Chief Executive Officer | 48 | 01-02-10 |
Chairman | 67 | 01-01-06 | |
John Benear
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 18 023 814 | 18 023 814 ( 100,00 %) | 0 | 100,00 % |
Bedrijfsgegevens
Parnell Pharmaceuticals Holdings Ltd.
Unit 4 Century Estate 476 Gardeners Road
2015, Sydney
+61 2 9667 4411
http://www.parnell.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,36% | 80,73 mld. | |
+22,21% | 9 mld. | |
+24,50% | 3,69 mld. | |
+0,28% | 3,28 mld. | |
+16,72% | 1,69 mld. | |
-0,20% | 1,31 mld. | |
-26,00% | 1,23 mld. | |
-29,34% | 1,18 mld. | |
-23,11% | 1 mld. |